2018-2023 Global Genetic Disease Diagnostic Market Report (Status and Outlook)

August 2018 | 116 pages | ID: 2EC3D147D55EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Genetic Disease Diagnostic market for 2018-2023.

Test the genetic disease. For example, color blindness, Down'ssyndrome, cystic fibrosis,etc
Rising incidences of genetic disorders that give rise to wide variety of independent diagnostic procedures globally is predominantly driving the growth of the global genetic disorder diagnostic market. Additionally, increasing awareness about prenatal diagnosis, rising attempt to improve patients quality of life and growing popularity of certain techniques such as gene therapy, medical genetics are further expected to boost market growth.
Over the next five years, LPI(LP Information) projects that Genetic Disease Diagnostic will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Genetic Disease Diagnostic market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Prenatal diagnosis
• Gene therapy

Segmentation by application:

• Inherited disorder testing
• Pharmacogenetic testing (PGx)
• Human leukocyte antigen (HLA) testing
• Oncology testing

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Abbott
• Celera Group
• Elitech Group
• PerkinElmer
• Quest Diagnostics
• AutoGenomics
• Roche Diagnostics
• BioRad
• Transgenomic
• Applied Biosystems

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Genetic Disease Diagnostic market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Genetic Disease Diagnostic market by identifying its various subsegments.
• Focuses on the key global Genetic Disease Diagnostic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Genetic Disease Diagnostic with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Genetic Disease Diagnostic submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Genetic Disease Diagnostic Market Size 2013-2023
  2.1.2 Genetic Disease Diagnostic Market Size CAGR by Region
2.2 Genetic Disease Diagnostic Segment by Type
  2.2.1 Prenatal diagnosis
  2.2.2 Gene therapy
2.3 Genetic Disease Diagnostic Market Size by Type
  2.3.1 Global Genetic Disease Diagnostic Market Size Market Share by Type (2013-2018)
  2.3.2 Global Genetic Disease Diagnostic Market Size Growth Rate by Type (2013-2018)
2.4 Genetic Disease Diagnostic Segment by Application
  2.4.1 Inherited disorder testing
  2.4.2 Pharmacogenetic testing (PGx)
  2.4.3 Human leukocyte antigen (HLA) testing
  2.4.4 Oncology testing
2.5 Genetic Disease Diagnostic Market Size by Application
  2.5.1 Global Genetic Disease Diagnostic Market Size Market Share by Application (2013-2018)
  2.5.2 Global Genetic Disease Diagnostic Market Size Growth Rate by Application (2013-2018)

3 GLOBAL GENETIC DISEASE DIAGNOSTIC BY PLAYERS

3.1 Global Genetic Disease Diagnostic Market Size Market Share by Players
  3.1.1 Global Genetic Disease Diagnostic Market Size by Players (2016-2018)
  3.1.2 Global Genetic Disease Diagnostic Market Size Market Share by Players (2016-2018)
3.2 Global Genetic Disease Diagnostic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GENETIC DISEASE DIAGNOSTIC BY REGIONS

4.1 Genetic Disease Diagnostic Market Size by Regions
4.2 Americas Genetic Disease Diagnostic Market Size Growth
4.3 APAC Genetic Disease Diagnostic Market Size Growth
4.4 Europe Genetic Disease Diagnostic Market Size Growth
4.5 Middle East & Africa Genetic Disease Diagnostic Market Size Growth

5 AMERICAS

5.1 Americas Genetic Disease Diagnostic Market Size by Countries
5.2 Americas Genetic Disease Diagnostic Market Size by Type
5.3 Americas Genetic Disease Diagnostic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Genetic Disease Diagnostic Market Size by Countries
6.2 APAC Genetic Disease Diagnostic Market Size by Type
6.3 APAC Genetic Disease Diagnostic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Genetic Disease Diagnostic by Countries
7.2 Europe Genetic Disease Diagnostic Market Size by Type
7.3 Europe Genetic Disease Diagnostic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Genetic Disease Diagnostic by Countries
8.2 Middle East & Africa Genetic Disease Diagnostic Market Size by Type
8.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL GENETIC DISEASE DIAGNOSTIC MARKET FORECAST

10.1 Global Genetic Disease Diagnostic Market Size Forecast (2018-2023)
10.2 Global Genetic Disease Diagnostic Forecast by Regions
  10.2.1 Global Genetic Disease Diagnostic Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Genetic Disease Diagnostic Forecast by Type
10.8 Global Genetic Disease Diagnostic Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Company Details
  11.1.2 Genetic Disease Diagnostic Product Offered
  11.1.3 Abbott Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Abbott News
11.2 Celera Group
  11.2.1 Company Details
  11.2.2 Genetic Disease Diagnostic Product Offered
  11.2.3 Celera Group Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Celera Group News
11.3 Elitech Group
  11.3.1 Company Details
  11.3.2 Genetic Disease Diagnostic Product Offered
  11.3.3 Elitech Group Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Elitech Group News
11.4 PerkinElmer
  11.4.1 Company Details
  11.4.2 Genetic Disease Diagnostic Product Offered
  11.4.3 PerkinElmer Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 PerkinElmer News
11.5 Quest Diagnostics
  11.5.1 Company Details
  11.5.2 Genetic Disease Diagnostic Product Offered
  11.5.3 Quest Diagnostics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Quest Diagnostics News
11.6 AutoGenomics
  11.6.1 Company Details
  11.6.2 Genetic Disease Diagnostic Product Offered
  11.6.3 AutoGenomics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 AutoGenomics News
11.7 Roche Diagnostics
  11.7.1 Company Details
  11.7.2 Genetic Disease Diagnostic Product Offered
  11.7.3 Roche Diagnostics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Roche Diagnostics News
11.8 BioRad
  11.8.1 Company Details
  11.8.2 Genetic Disease Diagnostic Product Offered
  11.8.3 BioRad Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 BioRad News
11.9 Transgenomic
  11.9.1 Company Details
  11.9.2 Genetic Disease Diagnostic Product Offered
  11.9.3 Transgenomic Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Transgenomic News
11.10 Applied Biosystems
  11.10.1 Company Details
  11.10.2 Genetic Disease Diagnostic Product Offered
  11.10.3 Applied Biosystems Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Applied Biosystems News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Genetic Disease Diagnostic
Figure Genetic Disease Diagnostic Report Years Considered
Figure Market Research Methodology
Figure Global Genetic Disease Diagnostic Ma